Pharmacy: State of the Art and Perspectives in USA (2nd Edition)

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 10 December 2024 | Viewed by 5753

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacy Practice and Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 20742, USA
Interests: precision medicine; utilization of long-acting injectable psychotropics; psychotropic medication adherence; role of the psychiatric pharmacist on the treatment team
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue aims to collect high-quality research articles, review articles, and discussions on all aspects of pharmacy education and practice in the United States. I encourage the submission of manuscripts that provide novel insights and applications, reporting on the advances in the education of student pharmacists and the practice of pharmacy. Topics of interest include, but are not limited to, the following:

  • Innovations in pharmacy education;
  • Entrusted professional activities of pharmacists;
  • Development in pharmacy practice;
  • Expanding the scope of practice for pharmacists during and after the COVID-19-pandemic;
  • Developments in pharmacy education during the pandemic.

Prof. Dr. Megan J. Ehret
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

11 pages, 470 KiB  
Article
Student Stress, Coping, and APPE Readiness at Two Public Institutions before and during the Pandemic
by Tram B. Cat, Shareen Y. El-Ibiary and Kelly C. Lee
Pharmacy 2024, 12(4), 121; https://doi.org/10.3390/pharmacy12040121 - 5 Aug 2024
Viewed by 860
Abstract
The coronavirus disease 2019 (COVID-19) pandemic significantly impacted pharmacy students’ education and well-being. The primary aim of this study was to evaluate the effects of the pandemic on students’ perceived stress by comparing third- and fourth-year students from the pre-pandemic Class of 2019 [...] Read more.
The coronavirus disease 2019 (COVID-19) pandemic significantly impacted pharmacy students’ education and well-being. The primary aim of this study was to evaluate the effects of the pandemic on students’ perceived stress by comparing third- and fourth-year students from the pre-pandemic Class of 2019 with mid-pandemic Class of 2021 at two public institutions. Secondary aims were to evaluate the pandemic effects on students’ academic and professional development skills and practice readiness. The Perceived Stress Scale (PSS) and the Brief Coping Orientation to Problems Experienced (COPE) scale were used to measure student well-being. Students’ self-rated problem-solving, time management, and study skills were used to measure their academic and professional development; practice readiness was measured using students’ self-rated confidence levels. PSS scores were significantly higher in mid-pandemic than pre-pandemic students, and the Brief COPE avoidant coping subscale differed between pre-pandemic and mid-pandemic students. No differences were found in any academic and professional development skills between the pre- and mid-pandemic students, and there were significant improvements in student confidence levels for practice readiness among the mid-pandemic students. In conclusion, the pandemic appeared to affect students’ stress and avoidant coping mechanism but had variable effects on academic and professional development and practice readiness. Full article
(This article belongs to the Special Issue Pharmacy: State of the Art and Perspectives in USA (2nd Edition))
Show Figures

Figure 1

Other

Jump to: Research

24 pages, 2510 KiB  
Perspective
Redesigning Pharmacy to Improve Public Health Outcomes: Expanding Retail Spaces for Digital Therapeutics to Replace Consumer Products That Increase Mortality and Morbidity Risks
by Grzegorz Bulaj, Melissa Coleman, Blake Johansen, Sarah Kraft, Wayne Lam, Katie Phillips and Aarushi Rohaj
Pharmacy 2024, 12(4), 107; https://doi.org/10.3390/pharmacy12040107 - 12 Jul 2024
Viewed by 2693
Abstract
United States healthcare outcomes, including avoidable mortality rates, are among the worst of high-income countries despite the highest healthcare spending per capita. While community pharmacies contribute to chronic disease management and preventive medicine, they also offer consumer products that increase mortality risks and [...] Read more.
United States healthcare outcomes, including avoidable mortality rates, are among the worst of high-income countries despite the highest healthcare spending per capita. While community pharmacies contribute to chronic disease management and preventive medicine, they also offer consumer products that increase mortality risks and the prevalence of cardiovascular diseases, diabetes, cancer, and depression. To resolve these contradictions, our perspective article describes opportunities for major pharmacy chains (e.g., CVS Pharmacy and Walgreens) to introduce digital health aisles dedicated to prescription and over-the-counter digital therapeutics (DTx), together with mobile apps and wearables that support disease self-management, wellness, and well-being. We provide an evidence-based rationale for digital health aisles to replace spaces devoted to sugar-sweetened beverages and other unhealthy commodities (alcohol, tobacco) that may increase risks for premature death. We discuss how digital health aisles can serve as marketing and patient education resources, informing customers about commercially available DTx and other technologies that support healthy lifestyles. Since pharmacy practice requires symbiotic balancing between profit margins and patient-centered, value-based care, replacing health-harming products with health-promoting technologies could positively impact prevention of chronic diseases, as well as the physical and mental health of patients and caregivers who visit neighborhood pharmacies in order to pick up medicines. Full article
(This article belongs to the Special Issue Pharmacy: State of the Art and Perspectives in USA (2nd Edition))
Show Figures

Figure 1

12 pages, 256 KiB  
Perspective
Nutrition’s Role in Quality Healthcare in the United States: Opportunities and Education for Pharmacists to Take a Bite of the Apple and Strengthen Their Skills
by Jeff Cai, Andie Lee Gonzalez and Mary Beth Arensberg
Pharmacy 2024, 12(4), 103; https://doi.org/10.3390/pharmacy12040103 - 29 Jun 2024
Viewed by 1455
Abstract
With global chronic disease rates on the rise, diet and nutrition remain pivotal yet under-appreciated aspects of healthcare, including in pharmacy practice. This perspective paper delves into how current United States health policies support nutrition’s role in healthcare and its integration into pharmacy [...] Read more.
With global chronic disease rates on the rise, diet and nutrition remain pivotal yet under-appreciated aspects of healthcare, including in pharmacy practice. This perspective paper delves into how current United States health policies support nutrition’s role in healthcare and its integration into pharmacy practice. The paper also reviews the landscape of nutrition education and training for pharmacists, pharmacy roles in multidisciplinary teams and interprofessional nutrition care, and the opportunities for post-graduate nutrition-focused certification, training, and continuing education. It advocates for a paradigm shift towards greater emphasis on nutrition within pharmacy practice, to improve skills and benefit quality patient nutrition care. Full article
(This article belongs to the Special Issue Pharmacy: State of the Art and Perspectives in USA (2nd Edition))
Back to TopTop